Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Strategy Inc Director's Dealing 2025

Nov 12, 2025

29883_dirs_2025-11-12_2233dc26-4940-4f9a-b7df-5e85030e24bd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Strategy Inc (MSTR)
CIK: 0001050446
Period of Report: 2025-11-10

Reporting Person: Shao Wei-Ming (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-11-10 Class A Common Stock M 5334 $69.123 Acquired 18060 Direct
2025-11-10 Class A Common Stock S 3767 $248.942 Disposed 14293 Direct
2025-11-10 Class A Common Stock S 1567 $249.555 Disposed 12726 Direct
2025-11-11 Class A Common Stock M 5334 $69.123 Acquired 18060 Direct
2025-11-11 Class A Common Stock S 3206 $234.749 Disposed 14854 Direct
2025-11-11 Class A Common Stock S 1539 $235.594 Disposed 13315 Direct
2025-11-11 Class A Common Stock S 589 $236.455 Disposed 12726 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-11-10 Employee Stock Option (Right to buy) $69.123 M 5334 Disposed 2031-02-23 Class A Common Stock (5334) Direct
2025-11-11 Employee Stock Option (Right to buy) $69.123 M 5334 Disposed 2031-02-23 Class A Common Stock (5334) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Series A Perpetual Strife Preferred Stock 500 Direct
Series A Perpetual Stretch Preferred Stock 15000 Direct
Series A Perpetual Stride Preferred Stock 3527 Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on July 11, 2025. As previously disclosed in Strategy Inc's ("Strategy") Current Report on Form 8-K filed with the Securities and Exchange Commission on July 1, 2025, the reporting person informed the issuer of his intention to retire effective December 31, 2025.

F2: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.435 to $249.40, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.

F3: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.52 to $250.04, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.

F4: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.25 to $235.17, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.

F5: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.39 to $236.235, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.

F6: The 5,334 shares exercised on November 10, 2025 pursuant to this option vested on February 23, 2022. Of the remaining 194,666 shares subject to this option, 44,666 shares vested on February 23, 2022, 50,000 shares vested on February 23, 2023, 50,000 shares vested on February 23, 2024 and 50,000 shares vested on February 23, 2025.

F7: The 5,334 shares exercised on November 11, 2025 pursuant to this option vested on February 23, 2022. Of the remaining 189,332 shares subject to this option, 39,332 shares vested on February 23, 2022, 50,000 shares vested on February 23, 2023, 50,000 shares vested on February 23, 2024 and 50,000 shares vested on February 23, 2025.